These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21208172)

  • 1. Pharmacokinetics and disposition of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles.
    Song X; Zhao X; Zhou Y; Li S; Ma Q
    Curr Drug Metab; 2010 Dec; 11(10):859-69. PubMed ID: 21208172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of nanoparticle-based delivery system via inner ear administration.
    Chen G; Zhang X; Yang F; Mu L
    Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
    Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
    Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
    Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
    Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable Thermosensitive PLGA-PEG-PLGA Polymer for Non-irritating and Sustained Ophthalmic Drug Delivery.
    Chan PS; Xian JW; Li Q; Chan CW; Leung SSY; To KKW
    AAPS J; 2019 Apr; 21(4):59. PubMed ID: 31020458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery.
    Shin SB; Cho HY; Kim DD; Choi HG; Lee YB
    Eur J Pharm Biopharm; 2010 Feb; 74(2):164-71. PubMed ID: 19703559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(lactide-
    Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
    ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium.
    Gholizadeh S; Kamps JAAM; Hennink WE; Kok RJ
    Int J Pharm; 2018 Sep; 548(2):747-758. PubMed ID: 29042337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of PLGA-mannosamine nanoparticles as oral protein carriers.
    Alonso-Sande M; des Rieux A; Fievez V; Sarmento B; Delgado A; Evora C; Remuñán-López C; Préat V; Alonso MJ
    Biomacromolecules; 2013 Nov; 14(11):4046-52. PubMed ID: 24131254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a non-toxic and non-denaturing formulation process for encapsulation of SDF-1α into PLGA/PEG-PLGA nanoparticles to achieve sustained release.
    Haji Mansor M; Najberg M; Contini A; Alvarez-Lorenzo C; Garcion E; Jérôme C; Boury F
    Eur J Pharm Biopharm; 2018 Apr; 125():38-50. PubMed ID: 29325770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
    Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
    Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
    Liu CW; Lin WJ
    J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits.
    Musumeci T; Bucolo C; Carbone C; Pignatello R; Drago F; Puglisi G
    Int J Pharm; 2013 Jan; 440(2):135-40. PubMed ID: 23078856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.
    Patel BK; Parikh RH; Patel N
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.
    Zhang J; Li Y; Gao W; Repka MA; Wang Y; Chen M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1367-80. PubMed ID: 24935153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
    Takeuchi I; Takeshita T; Suzuki T; Makino K
    Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
    Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
    J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.